Annual CFI
-$20.00 K
+$212.00 K+91.38%
01 June 2024
Summary:
Kintara Therapeutics annual cash flow from investing activities is currently -$20.00 thousand, with the most recent change of +$212.00 thousand (+91.38%) on 01 June 2024. During the last 3 years, it has fallen by -$984.00 thousand (-102.07%).KTRA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
01 June 2024
Summary:
Kintara Therapeutics quarterly cash flow from investing activities is currently $0.00, unchanged on 01 June 2024. Over the past year, it has stayed the same.KTRA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$20.00 K
$0.000.00%
01 June 2024
Summary:
Kintara Therapeutics TTM cash flow from investing activities is currently -$20.00 thousand, unchanged on 01 June 2024. Over the past year, it has dropped by -$20.00 thousand (-100.00%).KTRA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KTRA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +91.4% | 0.0% | -100.0% |
| 3 y3 years | -102.1% | 0.0% | -300.0% |
| 5 y5 years | - | 0.0% | -100.0% |
KTRA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -102.1% | -100.0% | -102.1% |
Kintara Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | -$20.00 K(-91.4%) | $0.00(0.0%) | -$20.00 K(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) | -$20.00 K(0.0%) |
| Dec 2023 | - | -$20.00 K(<-9900.0%) | -$20.00 K(<-9900.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2023 | -$232.00 K(<-9900.0%) | $0.00(0.0%) | -$232.00 K(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | -$232.00 K(0.0%) |
| Dec 2022 | - | $0.00(-100.0%) | -$232.00 K(0.0%) |
| Sept 2022 | - | -$232.00 K(<-9900.0%) | -$232.00 K(<-9900.0%) |
| June 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2021 | - | $0.00(0.0%) | -$8000.00(+60.0%) |
| Sept 2021 | - | $0.00(0.0%) | -$5000.00(-100.5%) |
| June 2021 | $964.00 K(>+9900.0%) | $0.00(-100.0%) | $964.00 K(0.0%) |
| Mar 2021 | - | -$8000.00(-366.7%) | $964.00 K(-0.8%) |
| Dec 2020 | - | $3000.00(-99.7%) | $972.00 K(+0.3%) |
| Sept 2020 | - | $969.00 K(>+9900.0%) | $969.00 K(>+9900.0%) |
| June 2020 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2019 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2018 | -$12.60 K(-40.0%) | $0.00(-100.0%) | -$12.60 K(-62.5%) |
| Mar 2018 | - | -$12.60 K(-40.0%) | -$33.60 K(+60.0%) |
| June 2017 | -$21.00 K(+25.0%) | -$21.00 K(<-9900.0%) | -$21.00 K(<-9900.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2016 | -$16.80 K(<-9900.0%) | $0.00(0.0%) | -$16.80 K(0.0%) |
| Mar 2016 | - | $0.00(-100.0%) | -$16.80 K(0.0%) |
| Dec 2015 | - | -$16.80 K(<-9900.0%) | -$16.80 K(<-9900.0%) |
| Sept 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2012 | $0.00(0.0%) | - | - |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00 | $0.00 |
| June 2010 | $0.00 | - | - |
FAQ
- What is Kintara Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Kintara Therapeutics?
- What is Kintara Therapeutics annual CFI year-on-year change?
- What is Kintara Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly CFI year-on-year change?
- What is Kintara Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Kintara Therapeutics?
- What is Kintara Therapeutics TTM CFI year-on-year change?
What is Kintara Therapeutics annual cash flow from investing activities?
The current annual CFI of KTRA is -$20.00 K
What is the all time high annual CFI for Kintara Therapeutics?
Kintara Therapeutics all-time high annual cash flow from investing activities is $964.00 K
What is Kintara Therapeutics annual CFI year-on-year change?
Over the past year, KTRA annual cash flow from investing activities has changed by +$212.00 K (+91.38%)
What is Kintara Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of KTRA is $0.00
What is the all time high quarterly CFI for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly cash flow from investing activities is $969.00 K
What is Kintara Therapeutics quarterly CFI year-on-year change?
Over the past year, KTRA quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Kintara Therapeutics TTM cash flow from investing activities?
The current TTM CFI of KTRA is -$20.00 K
What is the all time high TTM CFI for Kintara Therapeutics?
Kintara Therapeutics all-time high TTM cash flow from investing activities is $972.00 K
What is Kintara Therapeutics TTM CFI year-on-year change?
Over the past year, KTRA TTM cash flow from investing activities has changed by -$20.00 K (-100.00%)